Mind Medicine (MindMed), Inc. MNMD 深 滬
已收盤 01-14 16:00:00 美东时间
15.02
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 15.02
- 總市值 114.28万
- 52周最高 15.29
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 4.70
- 委 比 0.00%
- 總股本 7.61万
- 歷史最高 86.55
- 量 比 0
- 振 幅 0.00%
- 歷史最低 2.20
- 每 手 1
- 風險率 1.54%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多巨头并购、政策开闸、数据井喷……迷幻药变天前夜，市场收到一记38亿美元的多头信号
上周四，礼来公司(LLY.US)宣布将以高达38亿美元的价格收购临床阶段迷幻药物制造商AtaiBeckley(ATAI.US)。这一动作标志着，大型制药企业正日...
07-20 08:48
Definium Therapeutics launches $500M public offering
Definium Therapeutics (DFTX) announced plans for an underwritten public offering of $500M of common shares and, for certain investors, pre-funded warrants. Definium also intends to grant underwriters ...
06-23 04:08
Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia
The Therapeutic Goods Administration (TGA) in Australia has updated its framework for psychedelic-assisted therapy (PAT), expanding therapist eligibility, allowing treatment in diverse settings, and enhancing scalability. Optimi Health Corp., a Canadian psychedelic pharmaceutical company, supplies MDMA for PTSD and psilocybin for treatment-resistant depression under the updated Authorized Prescriber (AP) scheme. Key changes include multidisciplin...
05-29 12:30
Mind Medicine Inc. Nears Pivotal DT120 Data
Mind Medicine Inc. (($DFTX)) has held its Q1 earnings call. Read on for the mai...
05-09 08:57
Definium Therapeutics Anxiety Drug A Multi-Billion Opportunity: Analyst
Stifel starts Definium coverage, citing strong DT120 potential in anxiety and key 2026 trial catalysts shaping outlook.
04-18 02:06
Psyence BioMed Expands Australian Clinical Network To 5 Sites For Psilocybin Phase IIb Trial
syence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced the expansion
04-08 21:18
'Bipartisan Senators File Bill To Support Psychedelics Research And Treatment For Veterans' - Marijuana Moment
https://www.marijuanamoment.net/bipartisan-senators-file-bill-to-support-psychedelics-research-and-treatment-for-veterans/
03-28 01:28
Definium Therapeutics (Formerly Mind Medicine) Updates Nasdaq Listing Timeline; Common Shares To Begin Trading Under Ticker DFTX On January 15
Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.) (the "Company" or "Definium") is updating its previous announcement that the Company's Common Shares would begin trading on Nasdaq under the ticker
01-13 20:20
Definium Therapeutics Rebrands and Highlights 2026 Pipeline
Mind Medicine ( ($MNMD) ) just unveiled an announcement. On January 9, 2026, th...
01-12 21:56
